There is a major controversy regarding the suspicion that medications prescribed for the treatment of ADHD (attention-deficit/hyperactivity disorder) primarily act to control disruptive behavior as opposed to having primary effects on the ability to attend to the environment.
Thus, there is a continued need to better understand the neural basis of ADHD medication effects.
A new study in iBiological Psychiatry/i now provides evidence that methylphenidate and atomoxetine, two FDA-approved ...